155 related articles for article (PubMed ID: 37279205)
1. Clinical Characteristics Associated With Posttransplant Survival Among Adults 70 Years Old or Older Undergoing Liver Transplantation.
Wang M; Ge J; Ha N; Shui AM; Huang CY; Cullaro G; Lai JC
J Clin Gastroenterol; 2024 May-Jun 01; 58(5):516-521. PubMed ID: 37279205
[TBL] [Abstract][Full Text] [Related]
2. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
McCabe P; Galoosian A; Wong RJ
Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
[TBL] [Abstract][Full Text] [Related]
3. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
4. More Severe Deficits in Performance Status at Time of Liver Transplant is Associated With Significantly Higher Risk of Death Following Liver Transplantation.
McCabe P; Gish RG; Cheung R; Wong RJ
J Clin Gastroenterol; 2019 Oct; 53(9):e392-e399. PubMed ID: 30762610
[TBL] [Abstract][Full Text] [Related]
5. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
Kim JM; Kim DG; Kim J; Lee K; Lee KW; Ryu JH; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Cho JY; Hong G; Yu HC; Moon JI; Choi D; Hwang S; Kim MS
Clin Mol Hepatol; 2021 Jul; 27(3):451-462. PubMed ID: 33525077
[TBL] [Abstract][Full Text] [Related]
7. Karnofsky performance status before and after liver transplantation predicts graft and patient survival.
Thuluvath PJ; Thuluvath AJ; Savva Y
J Hepatol; 2018 Oct; 69(4):818-825. PubMed ID: 29883596
[TBL] [Abstract][Full Text] [Related]
8. Recipient Survival among Living Donor vs. Deceased Donor Liver Transplants for Acute Liver Failure in the United States.
Moughames E; Gurakar M; Khan A; Alsaqa M; Ozturk NB; Bonder A; Gurakar A; Saberi B
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541954
[No Abstract] [Full Text] [Related]
9. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
[TBL] [Abstract][Full Text] [Related]
11. The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children.
Ziogas IA; Schmoke N; Yoeli D; Cullen JM; Boster JM; Wachs ME; Adams MA
Pediatr Transplant; 2024 Feb; 28(1):e14641. PubMed ID: 37946593
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
Hu Z; Qian Z; Wu J; Zhou J; Zhang M; Zhou L; Zheng S
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):315-326. PubMed ID: 26382281
[TBL] [Abstract][Full Text] [Related]
15. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
[TBL] [Abstract][Full Text] [Related]
18. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
Thuluvath PJ; Yoo HY
Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
[TBL] [Abstract][Full Text] [Related]
19. Functional status, healthcare utilization, and the costs of liver transplantation.
Serper M; Bittermann T; Rossi M; Goldberg DS; Thomasson AM; Olthoff KM; Shaked A
Am J Transplant; 2018 May; 18(5):1187-1196. PubMed ID: 29116679
[TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
